Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Galenica Climbs After Raising 2012 Profit Forecast: Zurich Mover

Don't Miss Out —
Follow us on:

Aug. 14 (Bloomberg) -- Galenica AG, the world’s biggest maker of iron-replacement drugs, rose the most in more than nine months in Zurich after increasing its full-year profit forecast.

Galenica climbed as much as 4.5 percent, the biggest intraday advance since Nov. 11. The stock traded 3.9 percent higher at 581 Swiss francs as of 9:16 a.m. The shares have advanced 7.1 percent this year, including reinvested dividends, compared with a 12 percent gain in the Swiss Performance Index.

The Bern, Switzerland-based company expects profit to rise this year, it said as it reported first-half earnings today. Galenica said in March that 2012 profit would be unchanged.

First-half net income rose 13 percent to 119.6 million francs ($123 million), and sales advanced 2.2 percent to 1.62 billion francs.

To contact the reporter on this story: Simeon Bennett in Geneva at sbennett9@bloomberg.net

To contact the editor responsible for this story: Kristen Hallam at khallam@bloomberg.net